Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antineoplastic Agents, Immunological”

57 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 57 results

Large-scale testing (Phase 3)UnknownNCT01204801
What this trial is testing

Randomized Study of Combination Chemotherapy With or Without Focused Microwave Thermotherapy Before Surgery in Treating Women With Large Breast Cancer Tumors

Who this might be right for
Breast Cancer
Medifocus, Inc. 238
Early research (Phase 1)Study completedNCT02010606
What this trial is testing

Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma

Who this might be right for
GlioblastomaGlioblastoma MultiformeGlioma+2 more
Cedars-Sinai Medical Center 39
Testing effectiveness (Phase 2)Study completedNCT03680521
What this trial is testing

Neoadjuvant Sitravatinib in Combination With Nivolumab in Patients With Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
Mirati Therapeutics Inc. 25
Early research (Phase 1)Active Not RecruitingNCT04572451
What this trial is testing

Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma

Who this might be right for
MelanomaUnresectable Solid TumorsNeoplasms+7 more
Yana Najjar 50
Early research (Phase 1)Study completedNCT00000689
What this trial is testing

Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma

Who this might be right for
Lymphoma, Non-HodgkinHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 18
Testing effectiveness (Phase 2)Study completedNCT01507103
What this trial is testing

Tecemotide (L-BLP25) in Rectal Cancer

Who this might be right for
Rectal Cancer
Merck KGaA, Darmstadt, Germany 124
Early research (Phase 1)Study completedNCT06108479
What this trial is testing

Study of DF6215 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultSolid Tumor Cancer
Dragonfly Therapeutics 35
Post-approval studies (Phase 4)Ended earlyNCT05583188
What this trial is testing

Neoadjuvant Aliya™ PEF Soft Tissue Ablation With Systemic Therapy in Early-Stage Resectable NSCLC

Who this might be right for
NSCLC
Galvanize Therapeutics, Inc. 5
Testing effectiveness (Phase 2)UnknownNCT06134193
What this trial is testing

Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract Cancer

Who this might be right for
CarcinomaIntrahepatic CholangiocarcinomaGallbladder Cancer+5 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 41
Testing effectiveness (Phase 2)Active Not RecruitingNCT06606847
What this trial is testing

Investigate the Effects of Durvalumab With Oleclumab Following Chemoradiation in Participants With Locally Advanced Unresectable Non-Small Cell Lung Cancer (LADOGA)

Who this might be right for
Non-Small Cell Lung Cancer
AstraZeneca 30
Early research (Phase 1)Study completedNCT00002153
What this trial is testing

Topical Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenylhydrazone (A-007) in the Treatment of Advanced Malignancies Including Kaposi's Sarcoma and Lymphoproliferative Disorders

Who this might be right for
Sarcoma, KaposiHIV InfectionsLymphoproliferative Disorders
DEKK-TEC, Inc. 25
Testing effectiveness (Phase 2)Study completedNCT03369223
What this trial is testing

BMS-986249 Alone and in Combination With Nivolumab in Advanced Solid Tumors

Who this might be right for
Advanced Cancer
Bristol-Myers Squibb 356
Testing effectiveness (Phase 2)Study completedNCT00002188
What this trial is testing

ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma

Who this might be right for
Sarcoma, KaposiHIV Infections
Anderson Clinical Research 27
Early research (Phase 1)Study completedNCT00002136
What this trial is testing

A Phase I Trial of Tecogalan Sodium (DS-4152) Administered as an Infusion Every 21 Days

Who this might be right for
Sarcoma, KaposiHIV Infections
Daiichi Pharmaceuticals
Early research (Phase 1)Study completedNCT00002342
What this trial is testing

Tecogalan Sodium

Who this might be right for
Sarcoma, KaposiHIV Infections
Daiichi Pharmaceuticals
Testing effectiveness (Phase 2)UnknownNCT04922047
What this trial is testing

Safety and Efficacy Study of Tislelizumab in Combination With BCG in HR-NMIBC Patients (TACBIN-01)

Who this might be right for
Urinary Bladder NeoplasmsUrologic NeoplasmsUrogenital Neoplasms+3 more
RenJi Hospital 6
Early research (Phase 1)Study completedNCT00002137
What this trial is testing

A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Weekly x 4

Who this might be right for
Sarcoma, KaposiHIV Infections
Daiichi Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00005931
What this trial is testing

SU5416 in Patients With AIDS-Related Kaposi's Sarcoma Who Have Not Responded to Treatment

Who this might be right for
Sarcoma, KaposiHIV Infections
SUGEN 30
Testing effectiveness (Phase 2)Study completedNCT03349450
What this trial is testing

DPX-Survivac and Checkpoint Inhibitor in DLBCL

Who this might be right for
Adult Diffuse Large Cell LymphomaRecurrentAdult Refractory Diffuse Large B-Cell Lymphoma
Sunnybrook Health Sciences Centre 25
Early research (Phase 1)Study completedNCT00000763
What this trial is testing

A Phase I Study of TNP-470 in the Treatment of AIDS-Associated Kaposi's Sarcoma

Who this might be right for
Sarcoma, KaposiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 42
Next Page